-
Capsules with essential oils reduce symptoms of premenstrual syndromeA pill containing a mix of essential oils has been shown to significantly reduce the symptoms of premenstrual syndrome (PMS). Researchers writing in BioMed Central's open access journal Reproductive H2011/1/19
-
New Path to Destroy Breast Cancer Stem Cells FoundScientists at the University of Michigan Comprehensive Cancer Center in the US have identified a new 'indirect' route that could provide a means of targeting dangerous breast cancer stem cells. Res2011/1/19
-
DBA Announces New Name: NSF-DBADavid Begg Associates (DBA), an NSF International company with expertise in training, auditing and consultancy for the pharmaceutical and medical device industries, has changed its name to NSF-DBA. NS2011/1/18
-
Johnson & Johnson Sued Over Secret Motrin RecallJohnson & Johnson has been sued by the US State of Oregon following claims it secretly recalled defective painkiller Motrin, putting consumers at risk. Attorney general John Kroger claimed Joh2011/1/18
-
FDA Drug Safety Podcast: FDA Reduces Dose of Acetaminophen in Combination Prescription ProductsOn January 13, 2011, the Food and Drug Administration issued a drug safety communication announcing that all prescription combinations of opioids and acetaminophen can no longer contain more than 325m2011/1/17
-
ShangPharma opens new multi-purpose pharma development and cGMP manufacturing facility in FengxianShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement o2011/1/17
-
PPPI-III conference to focus on fundamental research and industrial application of particulate processingOver 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coa2011/1/14
-
Veeva Systems Introduces iRep Pharma App for iPadVeeva Systems has introduced the pharmaceutical industry's first complete customer relationship management and closed loop marketing application for the Apple iPad. iRep includes a sophisticated c2011/1/14
-
GlaxoSmithKline Slashes Price of NHS Parkinson's DrugGlaxoSmithKline has announced that it will reduce the price of ReQuip XL (ropinirole prolonged release) by 60% as part of a commitment to deliver cheaper medicines to the NHS. The NHS has rejected2011/1/13
-
Bayer Begins Enrolment for GIST Drug TrialBayer HealthCare has initiated patient enrolment for an international Phase III trial evaluating investigational regorafenib (BAY 73-4506) as a treatment for metastatic or unresectable gastrointestina2011/1/13